M1-c6v1

DB18596InvestigationalProtein Based Therapies

M1-c6v1 is a recombinant oncolytic virus.

Code names
M1-c6v1

What you can answer from here — as of April 02, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of M1-c6v1, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In